Status:
COMPLETED
Efficacy and Safety Trial to Evaluate the Effect of SCH 497079 on Weight in Obese and Overweight Participants (Study P05483)(COMPLETED)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Obesity
Overweight
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to evaluate the effect of SCH 497079 on weight in obese and overweight participants. The primary measure of effectiveness is the change in body weight during treatment. Ad...
Detailed Description
Following Screening, eligible participants will enroll in a Run-in Period. Participants who qualify for continuation in the study according to the entry criteria will be randomized to one of two treat...
Eligibility Criteria
Inclusion
- \>= 18 years of age, of either sex, and of any race.
- Obese or overweight participants.
Exclusion
- Participants who have a history of major eating disorders, gastrointestinal (GI) surgery, active serious cardiovascular, pulmonary, endocrine, neurologic, infectious, GI, hepatic, renal, hematologic, immunologic or psychiatric disease or diabetes.
Key Trial Info
Start Date :
June 9 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 30 2009
Estimated Enrollment :
401 Patients enrolled
Trial Details
Trial ID
NCT00642993
Start Date
June 9 2008
End Date
January 30 2009
Last Update
September 10 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.